Advanced Search
 

Email LinkedIn Twitter

Strategic Reports

Board members can now access our research archives. Join today and receive these Strategic Research Reports! Non-members can find these reports for sale in the Best Practices Database.
Complimentary Excerpt: Requip Case Study: Lifecycle Management - Reinvigorating a Mature Brand This document contains Metrics and Graphics.This document contains Metrics and Graphics.
To download this excerpt, click "Download Free Excerpt"... (ID MD-95)
Companies Profiled: GlaxoSmithKline
Non-Member Price: FREE   Free Excerpt Available
Oncology Marketing: Using Web Sites to Build Brand Equity and Loyalty This document contains Metrics and Graphics.This document contains Metrics and Graphics.

Study Overview

With easy access to information on the Internet, more people than ever are taking the responsibility of researching their own disease treatment options -- especially with such life-threatening illnesses as cancer... (ID 5375)
Companies Profiled: Abbott Laboratories, CTI Molecular Imaging, Genentech, Myriad, more ...
Non-Member Price: $1185.00
Utilizing Market Research in Managed Markets Functions This document contains Metrics, Graphics and a practice summary Matrix.This document contains Metrics, Graphics and a practice summary Matrix.This document contains Metrics, Graphics and a practice summary Matrix.
Commercial success of pharmaceutical products today depends increasingly upon understanding the needs of the commercial and government payers in the highly-influential Managed Markets sector... (ID 5025)
Companies Profiled: Abbott Laboratories, Ther-Rx, Xanodyne Pharmaceuticals, Novo Nordisk, more ...
Non-Member Price: $3995.00   Free Excerpt Available
Rituxan Case Study: Pre-Launch Communications to Change the Dominant Treatment Paradigm This document contains Graphics and a detailed Process Map.This document contains Graphics and a detailed Process Map.
Non-members: To download a complimentary excerpt of this study, please click here STUDY OVERVIEW This case study reviews the strategy and tactics utilized by Genentech for the Rheumatoid Arthritis (RA) indicated product, Rituxan, to communicate with KOLs regarding a new mechanism of action treatment for moderate-to-severe RA... (ID 5006)
Companies Profiled: Genentech
Non-Member Price: $4995.00   Free Excerpt Available
Exubera Case Study: Misjudging the Market This document contains Graphics.
Non-members: To download a complimentary excerpt of this study, please click here STUDY OVERVIEW This case study reviews the failed strategy and tactics utilized by Pfizer for the launch of its inhaled insulin product Exubera for diabetes... (ID 5005)
Companies Profiled: Pfizer
Non-Member Price: $2995.00   Free Excerpt Available

 
ACCESS AND INTELLIGENCE FOR ACHIEVING WORLD-CLASS EXCELLENCE
Quick Links  Product RSS Feed
  • Research & Consulting
  • Medical Affairs
  • Human Resources
    Process Improvement
  • Pharmaceutical Product
    Launch and Re-Launch
  • Benchmarking Reports
  • Excellence Services
  • Report Catalog
  • Best Practice Database
  • Medical Affairs
  • Competitive & Business Intelligence
  • Human Resources
  • Research and Advisory Services
  • Medical Affairs Consortium
  • Digital Technology Consortium
  • White Papers
  • Our Expertise
  • Medical Affairs
  • Competitive & Business Intelligence
  • Human Resource Management
  • Brand Management & Product Leadership
  • New Product launch
  • Pharmaceuticals
    • Payment gateway
    Secured by PayPal

    Follow Us: 

    linkedin twitter slideshare youtube google + pinterest

    All contents copyright 1998-2020 Best Practices, LLC (919) 403-0251
    Read our Terms and Conditions of Use, Privacy Policy and Copyright Information